Quarterly report pursuant to Section 13 or 15(d)

Consulting Agreements - Related Party (Details Textual)

v2.4.0.8
Consulting Agreements - Related Party (Details Textual) (USD $)
3 Months Ended 9 Months Ended 0 Months Ended
Sep. 30, 2014
Dec. 31, 2013
Sep. 30, 2014
ConsultingAgreement [Member]
Sep. 30, 2013
ConsultingAgreement [Member]
Sep. 30, 2014
ConsultingAgreement [Member]
Sep. 30, 2013
ConsultingAgreement [Member]
Oct. 03, 2011
Yeda [Member]
Related Party Transaction [Line Items]              
Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross             $ 210,000
Research and Development Arrangement, Contract to Perform for Others, Description and Terms             an annual Research budget commitment for 3 years in the amount of $800,000 for the period until October 3, 2014
ResearchAndDevelopmentArrangementContractToPerfromForOthersNonRefundableAmount             50,000
RoyaltyEffectivePercentage             4.00%
LicenseAgreementDescription             the option to license the organ regeneration technology originally expired on October 3, 2012 and has since been extended to September 1, 2014.
Accounts Payable and Accrued Liabilities, Current 134,000 442,000          
Operating Costs and Expenses     $ 184,000 $ 200,000 $ 795,000 $ 603,000